Compound Stems Damage from Brain Bleeding (2 of 2) (AUDIO)

American Association for the Advancement of Science (AAAS)

Caption

Study author Rajiv Ratan, from Burke Medical Research Institute in White Plains, NY, discusses a potential drug for brain hemorrhage called adaptaquin. This material relates to a paper that appeared in the March 2, 2016, issue of Science Translational Medicine, published by AAAS. The paper, by S.S. Karuppagounder at Burke Medical Research Institute in White Plains, N.Y., and colleagues was titled, "Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models."

Credit

S.S. Karuppagounder <i>et al.</i> / <i>Science Translational Medicine</i> (2016)

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.